CID supplement on HCV and injecting drug users: free online issue
A supplement from Clinical Infectious Diseases include a diverse range of articles on this important subject. Full text access is available free online.
Prevention and management of hepatitis C virus infection among people who inject drugs: moving the agenda forward
Clinical Infectious Diseases Vol. 57, suppl 2 – 15 August 2013.
- Prevention and management of hepatitis C virus infection among people who inject drugs: moving the agenda forward – Jason Grebely.
- Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention – Kimberly Page.
- Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy – Natasha K.
- Hepatitis C virus vaccines among people who inject drugs – Andrea Cox and David Thomas.
- Understanding barriers to hepatitis C virus care and stigmatisation from a social perspective – Carla Treloar, Jake Rance, and Markus Backmund.
- Models of care for the management of hepatitis C virus among people who inject drugs: one size does not fit all – Philip Bruggmann and Alain H. Litwin.
- Assessment and treatment of hepatitis C virus infection among people who inject ddrugs in the opioid substitution setting: ETHOS study – Maryam Alavi.
- Enhancing assessment and treatment of hepatitis C in the custodial setting – Jeffrey J. Post, Amber Arain, and Andrew R. Lloyd.
- Peer support models for people with a history of injecting drug use undertaking assessment and treatment for hepatitis C virus infection – Sione Crawford and Nicky Bath.
- Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis – Esther J. Aspinall.
- Directly observed pegylated interferon plus self-administered ribavirin for the treatment of hepatitis C virus infection in people actively using drugs: a randomized controlled trial – Robert J. Hilsden.
- Psychoeducation improves hepatitis C virus treatment during opioid substitution therapy: a controlled, prospective multicenter trial – Jens Reimer.
- Hepatitis C virus reinfection following treatment among people who use drugs – Bart P. Grady, Janke Schinkel, Xiomara V. Thomas, and Olav Dalgard.
- Management of mental health problems prior to and during treatment of hepatitis C virus infection in patients with drug addiction – Martin Schaefer, Rahul Sarkar, and Crisanto Diez-Quevedo.
- Management of hepatitis C virus/HIV coinfection among people who use drugs in the era of Direct-Acting Antiviral–based therapy – Lynn E. Taylor, Tracy Swan, and Gail V. Matthews.
- Drug-drug interactions in the treatment of HCV among people who inject drugs – Stefan Mauss and Hartwig Klinker
- Recommendations for the management of hepatitis C virus infection among people who inject drugs – Geert Robaeys,